Does anticoagulation increase the risk of wound hematoma in inguinal hernia surgery?

Hernia

Volumn 4, Issue 4, 2000, Pages 275-281

  Mumme, T ^a   Peiper, Ch ^a   Lorenz, N ^a   Junge, K ^a   Schumpelick, V ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Anticoagulation; Bleeding; Inguinal hernia; Thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DALTEPARIN; FRAGMIN P; HEPARIN;

ADULT; AGED; ANTICOAGULATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEART DISEASE; HEMATOMA; HEPARINIZATION; HERNIOPLASTY; HOSPITALIZATION; HUMAN; INGUINAL HERNIA; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 0034527160     PISSN: 12654906     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01201083     Document Type: Conference Paper

References (25)

1. Effect of long-term anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction
2. Incidence of venous thromboembolism in medical and surgical patients
3. Thrombosis and Virchow's triad: What is established?
4. Low dose heparin therapy in the long term management of venous thromboembolism
5. Anti-thrombotic therapy in patients with valvular heart disease and prosthetic heart valves
6. Randomized double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
7. Familiar thrombophilia due to previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
8. Antithrombotic therapy in atrial fibrillation
9. Thrombotic and bleeding complications of prosthetic heart valves
10. Prevention of venous thromboembolism
11. The natural history of idiopathic dilated cardiomyopathy
12. Left ventricular thrombi and cerebral embolism
13. Antithrombotic therapy in cardiac disease: An approach based on pathogenesis and risk stratification
14. Zur Abschätzung des Thromboserisikos in der Chirurgie und Traumatologie
15. Management of anticoagulation before and after elective surgery
16. Systemic embolism in chronic left ventricular aneurysm: Incidence and the role of anticoagulation
17. Effects of anaesthetic technique on deep vein thrombosis. A comparison of subarachnoid and general anaesthesia
18. Anticoagulant, antithrombotic and thrombolytic drugs
19. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism
20. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism
21. Pharmacologic control of thrombolic complications of cardiac-valve replacement
22. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial
23. Bleeding during antithrombotic therapy in patients with atrial fibrillation
24. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke prevention in atrial fibrillation II study